The abbott ambassador reviewed the abbottlink logs and observed abnormalities with the lls and pressure monitoring.No additional troubleshooting was performed.A specific cause for the discrepant result was not identified; therefore, the i2000sr analyzer was considered the likely cause.A review of the analyzer service history identified no contributing factors on or around the date of the complaint.There have been no subsequent occurrences of discrepant results.Further review of the customer's instrument logs were reviewed.Multiple level sense errors and sample pipettor movement restricted errors were observed on (b)(6), 2017.A review of the lls log shows an erratic pipettor step pattern for both the r1 and r2 total b-hcg reagent bottles which is suggestive of bubbles or foam in the reagent bottle or a fluidic-related hardware issue.A product labeling review found the architect systems operations manual addresses operational precautions and limitations; specimen handling recommendations and fluidic subsystems troubleshooting.The operations manual also addresses for i system depressed concentration and erratic results.The architect total b-hcg package insert addresses acceptable samples and provides recommendations for sample handling to ensure consistency in results.A review of the architect product monitoring found no similar issues as described in this complaint; no trend associated with the architect i2000sr erratic result rate was identified.Taken together, no systemic issue or deficiency of the architect i2000sr analyzer was identified.
|